Cargando…
Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide. Platinum-based chemotherapy is standard-of-care but has limitations including toxicity and resistance. Metal complexes of gold, ruthenium, and other metals have emerged as promising alternatives. This review pr...
Autores principales: | Xu, Xianzhi, Dai, Feng, Mao, Yiting, Zhang, Kai, Qin, Ying, Zheng, Jiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506097/ https://www.ncbi.nlm.nih.gov/pubmed/37727388 http://dx.doi.org/10.3389/fphar.2023.1242488 |
Ejemplares similares
-
Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria
por: Yang, Bingqing, et al.
Publicado: (2021) -
Unlocking the Mystery of the Therapeutic Effects of Chinese Medicine on Cancer
por: Liu, Shao-Hsiang, et al.
Publicado: (2021) -
Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer
por: Bijelic, Aleksandar, et al.
Publicado: (2018) -
Ruthenacarborane–Phenanthroline Derivatives as Potential Metallodrugs
por: Kellert, Martin, et al.
Publicado: (2020) -
Metallodrugs: an approach against invasion and metastasis in cancer treatment
por: González‐Ballesteros, Mauricio M., et al.
Publicado: (2022)